AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Megmanox 40mg Injection

Prescription Icon
Prescription Required

Marketer

Ridhima Biocare

Salt Composition

Enoxaparin (40mg)

Overview Megmanox 40mg Injection

Clotigen 40mg Injection, an anticoagulant medication, prevents and treats dangerous blood clots. It inhibits the growth of existing clots and hinders the formation of new ones. This injection is beneficial in preventing venous blood clots, specifically deep vein thrombosis and pulmonary embolism. Administration is subcutaneous, performed by a healthcare professional; intramuscular injection is contraindicated. Dosage and treatment duration are tailored to individual factors including medical history, response to treatment, underlying condition, age, and weight. Continued use is crucial, even without noticeable symptoms, as it safeguards against future complications; cessation may lead to clot formation. Activities increasing bleeding or injury risk should be avoided during treatment. Common side effects encompass injection site discomfort, hemorrhage, cephalalgia, thrombocytosis, respiratory distress, edema, anemia, pyrexia, diarrhea, and elevated liver enzymes. Severe headache may signal intracranial bleeding, while intense abdominal pain could indicate gastrointestinal bleeding. Bleeding, potentially subtle, is a serious concern; monitor for symptoms and report any worries to your physician. Prior to commencing treatment, disclose conditions such as hypertension, diabetes mellitus, or recent cerebrovascular accident. Contraindicated in patients with active bleeding. Inform your doctor about all other medications to ensure compatibility. Individuals with low body mass may experience heightened bleeding risk, further amplified by alcohol consumption, which increases the likelihood of gastrointestinal hemorrhage.

Uses of Megmanox 40mg Injection

Preventing and managing blood clots

Major Benefits of Megmanox 40mg Injection:

This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.

Common Side effects of Megmanox 40mg Injection:

  • Bleeding
  • Headache
  • Low blood platelets
  • Increased liver enzymes
  • Anemia (low number of red blood cells)
  • Fever
  • Injection site pain
  • Breathing problems
  • Edema (swelling)
  • Diarrhea

How to use Megmanox 40mg Injection:

Administering this medication will be handled by your healthcare provider. Self-medication is strongly discouraged.

How Megmanox 40mg Injection works:

Clotting is inhibited by the anticoagulant Megmanox 40mg Injection. Its mechanism involves neutralizing specific coagulation factors, thus hindering clot development and averting vascular obstructions.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Megmanox 40mg Injection may pose unknown risks. Seek medical advice before combining them.

PregnancyPregnancySAFE IF PRESCRIBED

Use of the injectable medication Megmanox 40mg during pregnancy is typically deemed safe. Preclinical trials in animals revealed minimal or no harmful consequences for fetal development; nevertheless, data from human trials are scarce.

Breast feedingBreast feedingSAFE IF PRESCRIBED

The use of Megmanox 40mg Injection during breastfeeding is likely safe. Available human data indicates minimal risk to the infant. The drug's transfer to breast milk is low, resulting in negligible infant exposure and an unlikely risk of adverse effects.

DrivingDrivingSAFE

Administering Megmanox 40mg Injection typically does not impair driving ability.

KidneyKidneyCAUTION

For individuals with impaired kidney function, administration of a 40mg Megmanox injection requires careful monitoring. Dosage modification may be necessary. Physician consultation is advised.

LiverLiverCONSULT YOUR DOCTOR

Insufficient data exists regarding Megmanox 40mg Injection administration to individuals with hepatic impairment. Physician consultation is recommended. Exercise prudence when prescribing to patients with pre-existing liver conditions.

What if you forget to take Megmanox 40mg Injection :

Should you forget a dose of the Megmanox 40mg Injection, seek your physician's advice.

Facts to Know About Megmanox 40mg Injection

LabelValue
Chemical Type Low-molecular-weight heparin (LMWH)
Developing Habits No.
Treatment Category KINSHIP
Action Class Low-molecular-weight heparin (LMWH)

FAQs on Megmanox 40mg Injection

Megmanox 40mg Injection is administered subcutaneously. Prepare the dose, pinch a stomach skin fold, and clean the area. Holding the syringe like a pencil, insert the needle fully into the fold, inject the medication, and dispose of the syringe as directed. Strictly adhere to your healthcare provider's instructions. Contact your doctor immediately if you experience any questions or adverse reactions.
Before starting Megmanox 40mg Injection, provide your doctor with a complete medical history. This includes disclosing any heart valve implants, gastric ulcers, high blood pressure, diabetes, kidney disease, prior heparin reactions, or recent stroke, brain, or spinal surgery. Pre-existing conditions may increase the risk of side effects. Follow your doctor's instructions carefully.
Store Megmanox 40mg Injection vials at 25°C; do not freeze. Multi-dose vials must be discarded 28 days after initial use. Discard the injection if discoloration, particulate matter, or syringe damage is observed. Consult the package leaflet or your pharmacist if you have any questions.
Megmanox 40mg Injection treats chest pain and heart attack, supplementing standard care. Administered with another anticoagulant, such as aspirin, it thins the blood, reducing the risk of further clotting and complications.
Yes, gently push any air bubbles into the injection site. Leaving air bubbles in the syringe reduces the medication's effectiveness, altering the intended dose.
Megmanox 40mg Injection
361
MRP 418
13% off